» Articles » PMID: 9797235

Central Role of Hemoglobin Degradation in Mechanisms of Action of 4-aminoquinolines, Quinoline Methanols, and Phenanthrene Methanols

Overview
Specialty Pharmacology
Date 1998 Oct 31
PMID 9797235
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

We have used a specific inhibitor of the malarial aspartic proteinase plasmepsin I and a nonspecific cysteine proteinase inhibitor to investigate the importance of hemoglobin degradation in the mechanism of action of chloroquine, amodiaquine, quinine, mefloquine (MQ), halofantrine, and primaquine. Both proteinase inhibitors antagonized the antiparasitic activity of all drugs tested with the exception of primaquine. An inhibitor of plasmepsin I, Ro40-4388, reduced the incorporation of radiolabelled chloroquine and quinine into malarial pigment by 95%, while causing a 70% reduction in the incorporation of radiolabelled MQ. Cysteine proteinase inhibitor E64 reduced the incorporation of chloroquine and quinine into malarial pigment by 60 and 40%, respectively. This study provides definitive support for the central role of hemoglobin degradation in the mechanism of action of the 4-aminoquinolines and the quinoline and phenanthrene methanol antimalarials.

Citing Articles

Stereospecific Resistance to N2-Acyl Tetrahydro-β-carboline Antimalarials Is Mediated by a PfMDR1 Mutation That Confers Collateral Drug Sensitivity.

Bremers E, Butler J, Do Amaral L, Merino E, Almolhim H, Zhou B ACS Infect Dis. 2025; 11(2):529-542.

PMID: 39808111 PMC: 11828674. DOI: 10.1021/acsinfecdis.4c01001.


Complementary crosstalk between palmitoylation and phosphorylation events in MTIP regulates its role during invasion.

Anam Z, Kumari G, Mukherjee S, Rex D, Biswas S, Maurya P Front Cell Infect Microbiol. 2022; 12:924424.

PMID: 36250062 PMC: 9556994. DOI: 10.3389/fcimb.2022.924424.


Different Drugs, Same End: Ultrastructural Hallmarks of Autophagy in Pathogenic Protozoa.

Pedra-Rezende Y, Macedo I, Midlej V, Mariante R, Menna-Barreto R Front Microbiol. 2022; 13:856686.

PMID: 35422792 PMC: 9002357. DOI: 10.3389/fmicb.2022.856686.


Xylopic acid-amodiaquine and xylopic acid-artesunate combinations are effective in managing malaria in Plasmodium berghei-infected mice.

Osei S, Biney R, Obese E, Agbenyeku M, Attah I, Ameyaw E Malar J. 2021; 20(1):113.

PMID: 33632233 PMC: 7908739. DOI: 10.1186/s12936-021-03658-6.


Spirofused tetrahydroisoquinoline-oxindole hybrids as a novel class of fast acting antimalarial agents with multiple modes of action.

Efange N, Lobe M, Keumoe R, Ayong L, Efange S Sci Rep. 2020; 10(1):17932.

PMID: 33087791 PMC: 7578093. DOI: 10.1038/s41598-020-74824-0.


References
1.
Cohen S, PHIFER K, Yielding K . COMPLEX FORMATION BETWEEN CHLOROQUINE AND FERRIHAEMIC ACID IN VITRO, AND ITS EFFECT ON THE ANTIMALARIAL ACTION OF CHLOROQUINE. Nature. 1964; 202:805-6. DOI: 10.1038/202805a0. View

2.
Foley M, Tilley L . Quinoline antimalarials: mechanisms of action and resistance. Int J Parasitol. 1997; 27(2):231-40. DOI: 10.1016/s0020-7519(96)00152-x. View

3.
Gluzman I, Francis S, Oksman A, Smith C, Duffin K, Goldberg D . Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway. J Clin Invest. 1994; 93(4):1602-8. PMC: 294190. DOI: 10.1172/JCI117140. View

4.
Warhurst D . Antimalarial interaction with ferriprotoporphyrin IX monomer and its relationship to activity of the blood schizontocides. Ann Trop Med Parasitol. 1987; 81(1):65-7. DOI: 10.1080/00034983.1987.11812093. View

5.
Asawamahasakda W, Ittarat I, Chang C, McElroy P, Meshnick S . Effects of antimalarials and protease inhibitors on plasmodial hemozoin production. Mol Biochem Parasitol. 1994; 67(2):183-91. DOI: 10.1016/0166-6851(94)00128-6. View